Mirae Asset Global Investments
BCYC

Mirae Asset Global Investments’s Bicycle Therapeutics BCYC Stock Holding History

Mirae Asset Global Investments’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.84K Sell
2,085
-332
-14% -$1.52K ﹤0.01% 1583
2026
Q1 		$11.2K Buy
2,417
+169
+8% +$966 ﹤0.01% 1492
2025
Q4 		$15.9K Buy
2,248
+461
+26% +$3.4K ﹤0.01% 1557
2025
Q3 		$13.8K Buy
1,787
+82
+5% +$619 ﹤0.01% 1536
2025
Q2 		$11.8K Buy
1,705
+241
+16% +$1.92K ﹤0.01% 1469
2025
Q1 		$13.1K Sell
1,464
-2
-0.1% -$24 ﹤0.01% 1440
2024
Q4 		$21.3K Buy
1,466
+124
+9% +$2.66K ﹤0.01% 1417
2024
Q3 		$31.1K Buy
1,342
+270
+25% +$6.23K ﹤0.01% 1375
2024
Q2 		$21.7K Buy
+1,072
New +$24.2K ﹤0.01% 1373

Other funds holding BCYC

PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Mirae Asset Global Investments's BCYC Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Bicycle Therapeutics (BCYC) stake by 14% in Q2 2026, selling an estimated $1.52K and leaving 2,085 shares worth $8.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

Mirae Asset Global Investments first reported a position in BCYC in Q2 2024 and has held it in 9 quarters since. The position peaked at $31.1K in Q3 2024. 27 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Mirae Asset Global Investments held 2,085 shares of Bicycle Therapeutics worth $8.84K as of Q2 2026.
  • Mirae Asset Global Investments sold 332 Bicycle Therapeutics shares in Q2 2026, an estimated $1.52K.
  • Bicycle Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1583 holding.
  • Mirae Asset Global Investments first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Bicycle Therapeutics position peaked at $31.1K in Q3 2024.
  • 27 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.